Publications
-
Abstracts (1)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Manuscripts (1)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Posters (0)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Pubs Strategy & Plan (0)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Reading References (6)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Folder 1 (6)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Folder 2 (5)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Abstracts (30)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
avatrombopag (3)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Disease State (2)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
lusutrombopag (25)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- CE Analysis of LUSU for the tx of TCP in CLD patients prior to an elective IP in Japan (ISPOR Asia Pacific 2020)
- LUSU_AASLD_82298 Obesity DM Abstract Submission Confirmation 2019-06-03v2.pdf
- LUSU_AASLD_Strong Effect of LUSU in Pts w CLD and relationship to renal function.pdf
- LUSU_Accepted_1546 EASL PMS Eff Saf Abstract SUBMISSION FINAL 2018-11-30 TC - EASL confirmed.docx
- LUSU_Accepted_82080 EASL 2019 PMS abstract 2018-Nov-12v2 Clean.docx
- LUSU_Accepted_82081 EASL Disease Aetiology Abstract_2018-Nov 16 ALL PARTS.docx
- LUSU_Accepted_82082 EASL Bleeding Events Abstract 2018 Nov 16 ALL PARTS.docx
- LUSU_Accepted_82083 EASL Pooled Safety Abstract 2018-Nov-16 ALL PARTS.docx
- LUSU_Accepted_82236 ACG Pooled Safety Submission Proof 2019-06-10v2.pdf
- LUSU_Accepted_82237 ACG Bleeding Events Submission Proof 2019-06-10v2.pdf
- LUSU_Accepted_AASLD HCC abstract_053118_Anno_Review_RB CLEAN.docx
- LUSU_Accepted_AASLD Integrated L-PLUS 1 L-PLUS 2 abstract 053018_Anno_Review docx-my_RB CLEAN.docx
- LUSU_Accepted_AASLD_Magnitude of PC Change.docx.docx
- LUSU_Accepted_EASL_2018 Real World Experience Abstract (Not Shionogi Sponsored).pdf
- LUSU_Accepted_Food effect_UEGW2018_abstract.pdf
- LUSU_Accepted_ISTH_82165 2019 Abstract Proof v2 Platelet Function.pdf
- LUSU_ACG_82236 Pooled Safety Submission Proof 2019-06-10v2.pdf
- LUSU_ACG_82237 Bleeding Events Submission Proof 2019-06-10v2.pdf
- LUSU_AGA_Effect of TPO-RA is higher than that of PT in CLD TCP_ Propensity Score Match.pdf
- LUSU_ISPOR abstract- lusu RCT meta analysis_final 120619 (submitted).docx
- LUSU_Not Accepted_82084 EASL CPC PMS Update abstract 2018 Nov 16 ALL PARTS.docx
- LUSU_Not Accepted_F_June1_Spontaneous AE reporting CLEAN.docx
- LUSU_Published_Joko 2019 Res Pract Thromb Haemost 12407_Platelet Function.pdf
- LUSU_Takeuchi_Relationship to Renal Function.pdf
- LUSU_Yoshida_Safe RFA for low platelet counts.pdf
-
-
Manuscripts (9)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- Alkhouri_Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular Carcinoma (2020)
- Hidaka_Lusutrombopag Reduces Need for PT in Pts With TCP Undergoing Invasive Procedures (2018)
- Katsube_PK/PD Modelling and Simulation of Lusutrombopag, a Novel TPO-RA, for the Tx of TCP in Pts with CLD Undergoing IPs (2019)
- Newland_A systematic literature review on the use of PTs in patients with TCP (2019)
- Peck_Lusutrombopag for the Tx of TCP in Pts With CLD Undergoing IPs [L-PLUS 2] (2019)
- Peck_Lusutrombopag for the Tx of TCP in Pts With CLD Undergoing IPs: Supplementary Tables [L-PLUS 2] (2019)
- Sasaki_Safety and effectiveness of lusutrombopag in Japanese CLD pts with TCP undergoing IPs: Interim results of a PMS (2019)
- Tateishi_A RCT of lusutrombopag in Japanese pts with CLD undergoing RFA (2018)
- Yoshida_Development of a new knock-in mouse model and evaluation of pharmacological activities of lusutrombopag, a novel, nonpeptidyl small-molecule agonist of the human thrombopoietin receptor c-Mpl (2018)
-
Posters (41)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
avatrombopag (2)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Disease State (5)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- Disease-State_Cardenas_EASL_2019_Lack of Benefit of PT in Pts with Cirrhosis and Esophageal Varices_EVL.pdf.jpg
- Disease-State_Poordad_AMCP_CLD_TCP.JPG
- Japan_ISPOR Europe_CLD_Poster_Final.pdf
- Spain_ISPOR 2019 Poster CLD-severe TCP Final.pdf
- Spain_ISPOR 2019 Poster Costs associated to CLD-severe TCP Final.pdf
-
lusutrombopag (34)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- LUSU_AANP_82230 Int Eff Analysis Poster 2019-06-06v1 Final.pdf
- LUSU_AANP_82231 MagChange 2019-06-06v1Final.pdf
- LUSU_AANP_82232 HCC Poster 2019-06-06v1 Final.pdf
- LUSU_AANP_82233 Safety Poster 2019-06-06v1Final.pdf
- LUSU_AANP_82234 Disease Etiol Poster 2019-06-06v2 Final.pdf
- LUSU_AANP_82235 BE Poster 2019-06-06v2 Final.pdf
- LUSU_AASLD Integrated_L-PLUS 1 and L-PLUS 2_11.6.18_Final.pdf
- LUSU_AASLD HCC_11.6.18_Final.pdf
- LUSU_AASLD Magnitude of Change_11.6.18_Final.pdf
- LUSU_ACG_82329 Safety Poster 2019-10-22 Final.pdf
- LUSU_ACG_82330 BE Poster 2019-Oct 7 Final.pdf
- LUSU_ASCPT_82164_DDI_Poster 2019-03-06v1.pdf
- LUSU_BASL_82341 BE Poster 2019-08-21v1 Final.pdf
- LUSU_BASL_82342 L-PLUS-1 Poster 2019-08-29v1 Final.pdf
- LUSU_BASL_82343 L-PLUS-2 Poster 2019-08-23v2 Final.pdf
- LUSU_BASL_82344 Safety Poster 2019-08-21v1 Final.pdf
- LUSU_BASL_82345 PMS Poster 2019-09-09v1 Final.pdf
- LUSU_CIRSE_82256 HCC Poster 29Jul2019 FINAL.pptx
- LUSU_CIRSE_82257 Bleeding Events Poster 29Jul2019v2 FINAL.pptx
- LUSU_CPP_PKPD Modeling_Katsube_PAGE2014_R_Poster.pdf
- LUSU_EASL 2018 Real World Experience Poster (Not Shionogi Sponsored).pdf
- LUSU_EASL_82159 PMS Poster 2019-04-02v4 Final.pdf
- LUSU_EASL_82160 Disease Aetiology Poster 2019-04-02v2 Final.pdf
- LUSU_EASL_82161 BE Poster 2019-04-04v2 - Final.pdf
- LUSU_EASL_82162 Safety Poster 2019-04-01v1 Final.pdf
- LUSU_EHA_82266 Int Eff Analysis Poster 2019-05-30v3 Final.pdf
- LUSU_EHA_82267 MagChange 2019-05-30v2 Final.pdf
- LUSU_EHA_82268 HCC Poster 2019-05-30v1 Final.pdf
- LUSU_EHA_82269 Safety Poster 2019-05-30v1 Final.pdf
- LUSU_EHA_82270 BE Poster 2019-05-30v1 Final.pdf
- LUSU_EHA_82271 PMS Poster 2019-05-30v2 Final.pdf
- LUSU_ISPOR EU meta-analysis Poster FINAL.pdf
- LUSU_ISTH_82295 Platelet Function Poster 2019-06-21 FINAL.pdf
- LUSU_UEGW_18-1388 1424737_Shionogi food_effect Poster_v5.pdf
-
-
Pubs Strategy & Plan (2)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Reading References (47)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- Afdhal_ELEVATE (2012)
- Afdhal_ELEVATE_Supplementary Data (2012)
- Afdhal_TCP Associated with CLD (2008)
- Barnett_Cost Estimate of PT (June 2018)
- Basili_PC Does Not Predict Bleeding in Cirrhotic Pts: Results from the PRO-LIVER Study (2018)
- Benson_Differential Effect of Plasma and Red Blood Cell Transfusion on ALI and Infection Risk following Liver Transplantation (2011)
- Blachier_Burden of Liver Disease in Europe: Review of Epi Data (2013)
- Blumberg_PTs: trigger, dose, benefits, and risks (2010)
- Brown_Review Article: a PE Analysis of CLD TCP (2007)
- Bussell_Avatrombopag (2017)
- Caram_Deelder_Effect of Platelet Storage Time on Platelet Measurements: A Systematic Review and Meta-analyses (2016)
- de Gottardi_Risk of Complications After Abdominal Paracentesis in Cirrhotic Patients: A Prospective Study (2009)
- de Gottardi_Risk of Complications After Abdominal Paracentesis in Cirrhotic Patients: A Prospective Study_Supplemental Table (2009))
- Elsaid_The burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease (2019)
- Giannini_A Closer Look at Factors Associated With Bleeding in Cirrhotic Pts_Editorial Response (2018)
- Giannini_Incidence of Bleeding Following IPs in Pts With TCP and Advanced Liver Disease (2010)
- Giannini_Review Article: CLD TCP and Pharmacologic Tx Options
- Hannon_Transfusion Guidelines: Development and Impact on Patient Blood Management (2013)
- Katsube_PK/PD Modelling and Simulation of Lusutrombopag, a Novel TPO-RA, for the Tx of TCP in Pts with CLD Undergoing IPs (2019)
- Kuter_Avatrombopag, an oral TPO_RA: Results of 2 Double-blind, Dose-rising, PBO-controlled Ph 1 Studies (2018)
- Mladsi_Cost effectiveness of Avatrombopag for the TCP in Pts with CLD (2020)
- Nagrebetsky_Perioperative TCP: evidence, evaluation, and emerging therapies (2019)
- Newland_A systematic literature review on the use of PTs in patients with TCP (2019)
- Ning_Platelet Transfusion Practices in the ICU (2016)
- Olson_CLD, TCP and Procedural Bleeding Risk; Are Novel TPO Mimetics the Solution? (2018)
- Peck_Lusutrombopag for the Tx of TCP in Pts With CLD Undergoing IPs [L-PLUS 2] (2019)
- Peck_Lusutrombopag for the Tx of TCP in Pts With CLD Undergoing IPs: Supplementary Tables [L-PLUS 2] (2019)
- Peck_TCP in CLD (2016)
- Pietri_Thrombelastography-Guided Blood Product Use Before IPs in Cirrhosis With Severe Coagulopathy: A RCT (2016)
- Poordad_Avatrombopag, an Alternate Tx Option to Reduce PTs in Pts with CLD TCP: Integrated Analyses of 2 Ph 3 Studies (2020)
- Poordad_Evaluating Medical Resource Ux and Costs Associated with TCP CLD Pts (2011)
- Poordad_Medical Resource Ux and HC Costs in Pts with Chronic Hep C and TCP (2011)
- Poordad_Review Article: TCP in CLD (2007)
- Riley_Using lean techniques to define the PT process and CE to evaluate PT dose strategies (2012)
- Saab_Management of TCP CLD Patients
- Sasaki_Safety and effectiveness of lusutrombopag in Japanese CLD pts with TCP undergoing IPs: Interim results of a PMS (2019)
- Takada_Real-life experience of lusutrombopag for cirrhotic pts with low PCs being prepared for IPs (2019)
- Tateishi_A RCT of lusutrombopag in Japanese pts with CLD undergoing RFA (2018)
- Terrault_Avatrombopag Before Procedures Reduces Need for PT in Pts With CLD TCP (2018)
- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020)
- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017: Supplemental Appendix (2020)
- Tripodi_Global Hemostasis Tests in PTs with Cirrhosis before and after Prophylactic PT (2012)
- Uojima_Relationship between response to lusutrombopag and splenic volume (2019)
- Violi_Incidence and Recurrence of PVT in Cirrhotic Pts (2018)
- von Herbay_Color Doppler Sonographic Evaluation of Spontaneous Portosystemic Shunts and Inversion of Portal Venous Flow in Pts with Cirrhosis (2000)
- Yoshida_Development of a new knock-in mouse model and evaluation of pharmacological activities of lusutrombopag, a novel, nonpeptidyl small-molecule agonist of the human thrombopoietin receptor c-Mpl (2018)
- Zhou_Perioperative safety analysis of TACE for HCC pts with pre-procedural leukopenia or TCP (2017)
-
Abstracts (0)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Manuscripts (0)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Posters (0)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Pubs Strategy & Plan (0)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Reading References (0)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Abstracts (5)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- X. New Email Test - 25/09/2020
-
EPI (2)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
gefapixant (1)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Measures_Assessment_Tx (1)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Manuscripts (0)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Posters (17)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Bayer (1)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Burden (4)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- McGarvey_Prevalence of CC, Patient Characteristics, and Health Outcomes among UK Adults (2019)
- Morice_The burden of coughing: a retrospective observational study in the UK (2019)
- Zeiger_Characteristics and Burden of CC in Adults in a Large MCO: KPSC (2019)
- Zeiger_Identification and Burden of CC in Adults in a Large MCO: KPSC (2020)
-
EPI (3)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
gefapixant (7)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- Birring_A Ph 3b Trial Evaluating the Efficacy of Gefapixant in Reducing SUI in Women With CC (2020)
- Birring_Baseline Patient Burden in Chronic Cough From a Phase 2b Clinical Trial of Gefapixant, a P2X3 Receptor Antagonist (2019)
- Birring_Relationship Between HRQoL and Objective Cough Frequency in a Phase 2b Trial of Gefapixant (2019)
- Hussain_Dose Selection for Two Ph 3 RCTs (COUGH-1 and COUGH-2) in Refractory or Unexplained CC (2020)
- McGarvey_Characterization of Chronic Cough Patients Participating in a Phase 2b Clinical Trial of Gefapixant, a P2X3 Receptor Antagonist (2019)
- Morice_Responder Analyses Evaluating Treatment Effects Over Time with Gefapixant in a Ph 2b Study of Refractory or Unexplained CC (2020)
- Weiner_Health-related Experiences of Adults with CC (2020)
-
PRO_Utilities (2)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
-
Pubs Strategy & Plan (0)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Reading References (58)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
Burden (1)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
EPI (15)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- Adams_Associations of physical and mental health problems with CC in a representative population cohort (2009)
- Bende_Prevalence of chronic cough in relation to upper and lower airway symptoms: the Skovde population-based study (2012)
- Chamberlain_The Impact of CC: A Cross-Sectional European Survey (2015)
- Colak_Risk Factors for CC Among 14,669 Individuals From the General Population (2017)
- Everett_Chonic persistent cough in the community: a questionnaire survey_Question Set (2007)
- Everett_Chronic persistent cough in the community: a questionnaire survey
- Fujimura_Frequency of Persistent Cough and Trends in Seeking Medical Care and Treatment - Results of an Internet Survey (2012)
- Fujimura_Frequency of Persistent Cough and Trends in Seeking Medical Care and Treatment - Results on an Internet Survey: Questionnaire (2012)
- Holden_Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity? (2019)
- Holden_Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity? Supplemental Material (2019)
- Kang_Impact of Cough and Unmet Needs in CC: A Survey of Patients in Korea (2019)
- Koskela_The impacts of cough: a cross-sectional study in a Finnish adult ee population (2018)
- Matsumoto_Risks and Cough-Aggravating Factors in Prolonged Cough_Epidemiological Observations from the Nagahama Cohort Study (2017)
- Morice_A worldwide survey of CC: a manifestation of enhanced somatosensory response (2014)
- Woo Joo_The global epi of CC in adults: a systematic review and meta-analysis (2015)
-
gabapentin_pregabalin (2)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
gefapixant (7)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- Abdulqawi_P2X3 receptor antagonist (AF-219) in RCC: a randomised, double-blind, PBO-controlled ph 2 study (2015)
- Morice_The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised PBO-controlled study (2019)
- Muccino_Update on the clinical development of gefapixant, a P2X3 RA for the treatment of RCC (2019)
- Richards_Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation (2018)
- Smith_Gefapixant in two randomised dose-escalation studies in CC (2020)
- Smith_Gefapixant, a P2X3 RA, for the tx of refractory or unexplained CC: a randomised, double-blind, controlled, parallel-group, phase 2b trial (2020)
- Smith_Gefapixant, a P2X3 RA, for the tx of refractory or unexplained CC: a randomised, double-blind, controlled, parallel-group, phase 2b trial; SUPPLEMENT (2020)
-
Guidelines (6)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- Boulet_ Tools for Assessing Outcomes in Studies of CC_CHEST Guideline and Expert Panel Report (2015)
- Gibson_Treatment of Unexplained Chronic Cough CHEST Guideline and Expert Panel Report (2016)
- Irwin_Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report (2018)
- Kardos_Guidelines of the German Respiratory Society for Dx and Tx of Adults Suffering from Acute, Subacute and CC (2019)
- Morice_ERS Guidelines on the Assessment of Cough (2007)
- Morice_ERS Guidelines on the Dx and Tx of CC in Adults and Children (2020)
-
Measures_Assessment_Tx (13)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- Boulet_ Tools for Assessing Outcomes in Studies of CC_CHEST Guideline and Expert Panel Report (2015)
- Cho_Methods of Cough Assessment (2019)
- Gibson_Management of CRC (2015)
- Irwin_Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report (2018)
- Macedo_Analysis of bronchial biopsies in CC (2017)
- McGarvey_Neurocough Network (2019)
- McGarvey_What_Is_Chronic_Cough_Terminology (2019)
- Pacheco_Chronic Cough (2015)
- Pacheco_RCC: New Perspectives in Dx and Tx (2013)
- Perotin_Managing patients with CC: challenges and solutions (2018)
- Ryan_An update and systematic review on drug therapies for the tx of RCC (2018)
- Smith_Chronic Cough (2016)
- Soni_Tx of CC: Single-Institution Experience Utilizing Behavioral Therapy (2017)
-
Pathophysiology (4)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
PRO_Utilities (7)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
- Cho_CC_ health status assessment with EQ-5D-5L questionnaire (2017)
- Nguyen_Quantitative measurement properties and score inpretation of CSD in pts with CC (2020)
- Sinha_The Use of Online Health Forums by Patients With Chronic Cough: Qualitative Study (2018)
- Vernon_Measuring cough severity: development and pilot testing of a new seven-item cough severity PRO measure (2010)
- Vernon_Measuring cough severity: Perspectives from the literature and from patients with CC (2009)
- Vertigan_Development and validation of the Newcastle laryngeal hypersensitivity questionnaire (2014)
- Wang_Types and applications of cough-related questionnaires (2019)
-
Reviews (3)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts
-
-
Presentations (Congresses) (1)Available Actions:Add Folder Edit Folder Delete Folder Add File Email Message Move Files from Folder Add to Shortcuts